Effects of Add-on Ramelteon on Cognitive Impairment in Patients with Schizophrenia: An Open-label Pilot Trial

OBJECTIVE: This open-label study examined the effects of ramelteon on cognitive functions in 10 outpatients with schizophrenia. METHODS: Ramelteon (8 mg/day) was administered to 10 patients with schizophrenia for six months. The verbal fluency test, Trail-Making Test, the Wisconsin Card Sorting Test...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Psychopharmacol Neurosci
Päätekijät: Shirayama, Yukihiko, Takahashi, Michio, Suzuki, Masatoshi, Tsuruoka, Yoshiaki, Sato, Koichi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Korean College of Neuropsychopharmacology 2014
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4293167/
https://ncbi.nlm.nih.gov/pubmed/25598825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9758/cpn.2014.12.3.215
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia